Capricor Therapeutics
CAPR
#8011
Rank
C$0.40 B
Marketcap
C$8.79
Share price
-4.36%
Change (1 day)
-56.29%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -C$0.12 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are C$11.13 Million. In 2024 the company made an earning of -C$55.94 Million a decrease over its 2023 earnings that were of -C$30.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.12 Billion105.2%
2024 -C$55.94 Million81.57%
2023 -C$30.81 Million-23.2%
2022 -C$40.12 Million44.93%
2021 -C$27.68 Million46.61%
2020 -C$18.88 Million78.71%
2019 -C$10.57 Million-49.7%
2018 -C$21 Million-724.78%
2017 C$3.36 M-112.93%
2016 -C$26 Million46.27%
2015 -C$17.78 Million106.82%
2014 -C$8.6 Million-48.41%
2013 -C$16.66 Million977.23%
2012 -C$1.55 Million-77.11%
2011 -C$6.76 Million-22.35%
2010 -C$8.7 Million-20.17%
2009 -C$10.9 Million-41.17%
2008 -C$18.53 Million41.05%
2007 -C$13.14 Million1098.87%
2006 -C$1.1 Million4101.55%
2005 -C$0.03 Million-0.97%
2004 -C$0.03 Million17.87%
2003 -C$0.03 Million3.66%
2002 -C$0.03 Million-30.11%
2001 -C$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-C$1.04 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$6.63 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.77 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$0.80 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.36 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.12 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA